CCT5 p.Ala437Val
c.1310C>T · rs149067488 · VCV575826
Computational evidence
| Protein change | ||
| AlphaMissense | 0.7933 | likely pathogenic |
|---|---|---|
| REVEL | 0.848 | moderately pathogenic-leaning |
| SaProt | LLR -13.90 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.9 | GERP 2.6, phastCons 1 |
| Regional constraint | o/e 0.69 | unconstrained · MANE · 7,066 bp · p 1.6e-09 · regional, not allelic |
| Overall | ||
| CADD | 25.4 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,830 |
| European (non-Finnish)grpmax | 0.00466% | 21,455 |
| South Asian | 0.00439% | 22,772 |
| East Asian | 0.00223% | 44,894 |
| Admixed American | 0.00167% | 60,002 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CCT5
- Protein
- p.Ala437Val
- Coding
- c.1310C>T
- MANE Select
- NM_012073
- dbSNP
- rs149067488
- Type
- single nucleotide variant
- Location
- chr5:10262611 (GRCh38)
- Gene constraint
- LOEUF 0.235 · pLI 1.00 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 89.34 · 75 PDB
- Residue 437
- an α-helix
Disease context
hereditary sensory and autonomic neuropathy with spastic paraplegia — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Mutilating hereditary sensory neuropathy with spastic paraplegia (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood, Infancy
Similar variants
- CCT5 p.Ala437= Likely benign ★ same residue
- CCT5 c.531-3C>T Uncertain significance ★★ same condition
- CCT5 c.*1126T>A Uncertain significance ★★ same condition
- CCT5 c.*567G>A Uncertain significance ★★ same condition
- CCT5 p.Ala246Val Uncertain significance ★★ ⚠ same condition
- CCT5 p.Ala41Gly Uncertain significance ★★ ⚠ same condition
- CCT5 p.Ala424Ser Uncertain significance ★★ ⚠ same condition
- CCT5 p.Arg142Cys Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cct5-p-ala437val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown